Skip to main content

Table 2 Sociodemographic and medical characteristics of the sample (n = 577)

From: Psychometric properties of the fatigue questionnaire EORTC QLQ-FA12 and proposal of a cut-off value for young adults with cancer

Sociodemographic characteristics N (%)
Sex 577 (100.0)
 Male 153 (26.5)
 Female 424 (73.5)
Age at Interview (M = 30.3, SD = 6.1) 577 (100.0)
 18 to < 26 years 164 (28.4)
 26 to < 42 years 413 (71.6)
Education 573 (100.0)
 No educational degree/student 6 (1.0)
 Basic educational degree (< 10 years) 37 (6.5)
 Secondary educational degree (10 years) 190 (33.2)
 Highschool degree (> 10 years) 340 (59.3)
Medical characteristics N (%)
Age at Diagnosis (M = 29.3, SD = 6.1) 577 (100.0)
 18 to < 26 years 184 (31.9)
 26 to < 40 years 393 (68.1)
Time since Diagnosis (M = 11.9, SD = 8.0) 577 (100.0)
 up to 2 months 8 (1.4)
 > 2 to 4 months 38 (6.6)
 > 4 to 6 months 69 (12.0)
 > 6 to 12 months 269 (46.6)
 > 12 to 24 months 145 (25.1)
 more than 24 months 48 (8.3)
Diagnosis 577 (100.0)
 Breast Cancer [C50] 150 (26.0)
 Hodgkin Lymphoma [C81] 99 (17.2)
 Gynecological Cancer [C51-C57] 51 (8.8)
 Testicular Cancer [C62] 50 (8.7)
 Non-Hodgkin Lymphoma [C82-C90] 42 (7.3)
 Haematological Cancer [C91-C95] 38 (6.6)
 Thyroid Cancer [C73] 32 (5.5)
 Gastrointestinal Cancer [C15-C26] 29 (5.0)
 Sarcoma [C40-C41, C46-C49] 26 (4.5)
 Melanoma [C43] 19 (3.3)
 Other C, D00-D48 and Carcinoma in situ 41 (7.1)
Therapiesa, b 577 (100.0)
 Chemotherapyc 443 (76.8)
 Radiotherapyd 264 (45.8)
 Surgery 427 (74.0)
 Neither chemo- nor radiotherapy 85 (14.7)
  1. amultiple answers possible; b Due to further validation of data there are deviations to the baseline medical therapies published in the study protocol [49].; c including Radio-Chemotherapy; d including nuclear therapies and Radio-Chemotherapy